1. Home
  2. RACE vs COR Comparison

RACE vs COR Comparison

Compare RACE & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferrari N.V.

RACE

Ferrari N.V.

N/A

Current Price

$346.12

Market Cap

67.2B

ML Signal

N/A

Logo Cencora Inc.

COR

Cencora Inc.

N/A

Current Price

$353.68

Market Cap

68.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RACE
COR
Founded
1947
2001
Country
Italy
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Other Pharmaceuticals
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.2B
68.5B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
RACE
COR
Price
$346.12
$353.68
Analyst Decision
Strong Buy
Buy
Analyst Count
10
13
Target Price
$488.14
$395.23
AVG Volume (30 Days)
821.6K
982.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
0.98%
0.67%
EPS Growth
N/A
5.71
EPS
N/A
2.87
Revenue
N/A
$321,332,819,000.00
Revenue This Year
$7.64
$8.97
Revenue Next Year
$7.41
$6.76
P/E Ratio
$34.59
$124.57
Revenue Growth
N/A
9.31
52 Week Low
$328.00
$251.94
52 Week High
$519.10
$377.54

Technical Indicators

Market Signals
Indicator
RACE
COR
Relative Strength Index (RSI) 40.75 44.65
Support Level $328.00 $331.73
Resistance Level $381.03 $376.45
Average True Range (ATR) 7.70 7.17
MACD -3.02 -1.63
Stochastic Oscillator 18.38 10.19

Price Performance

Historical Comparison
RACE
COR

About RACE Ferrari N.V.

Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2025, the company sold 13,640 vehicles at an average price over EUR 500,000 with more than 80% of its vehicles being sold to existing Ferrari clients. Eighty-four percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2025, the Europe, Middle East, and Africa region accounted for 49% of revenue, the Americas was 32%, mainland China, Hong Kong, and Taiwan was 7%, and the rest of Asia was 12%.

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: